TL;DR
Post-inflammatory hyperpigmentation (PIH) is one of the most common and frustrating skin concerns encountered in both dermatology and aesthetic practice. The darkened patches that follow skin inflammation — whether from…
Last updated: 5 March 2026
Post-inflammatory hyperpigmentation (PIH) is one of the most common and frustrating skin concerns encountered in both dermatology and aesthetic practice. The darkened patches that follow skin inflammation — whether from acne, injury, or aesthetic procedures themselves — can persist for months or even years, affecting skin tone uniformity and patient confidence. PIH disproportionately affects individuals with darker skin tones, making it a particularly important consideration in diverse populations. This comprehensive guide examines the causes, prevention, and evidence-based treatment approaches for PIH.
Understanding Post-Inflammatory Hyperpigmentation
PIH occurs when inflammation triggers excessive melanin production in the skin. Melanocytes — the pigment-producing cells — are stimulated by inflammatory mediators (prostaglandins, leukotrienes, and cytokines) to increase melanin synthesis through the enzyme tyrosinase. This excess melanin is either deposited in the epidermis (producing brown discolouration) or drops into the dermis through a process called melanin incontinence (producing blue-grey discolouration).
Epidermal vs. Dermal PIH
The distinction between epidermal and dermal PIH is clinically important because it determines the prognosis and treatment approach. Epidermal PIH appears as tan to dark brown patches that enhance under Wood’s lamp (ultraviolet) examination. It responds relatively well to topical treatments and typically resolves within 6-12 months. Dermal PIH appears as blue-grey or dark grey patches that do not enhance under Wood’s lamp. It is more resistant to treatment and may persist for years or become permanent.
Common Causes
Virtually any inflammatory event can trigger PIH. Common causes include acne (the most frequent cause, particularly in darker skin tones), eczema and contact dermatitis, psoriasis, insect bites and skin trauma, burns (including sunburn), aesthetic procedures (laser treatments, chemical peels, microneedling), allergic reactions, and infections (including fungal infections).
| PIH Type | Colour | Depth | Wood’s Lamp | Treatment Response | Resolution Time |
|---|---|---|---|---|---|
| Epidermal | Tan to dark brown | Epidermis | Enhanced (more visible) | Good | 3-12 months |
| Dermal | Blue-grey | Dermis | Not enhanced | Poor to moderate | Months to years |
| Mixed | Brown-grey | Both | Partially enhanced | Moderate | Variable |
Risk Factors
Certain factors increase the risk and severity of PIH. Fitzpatrick skin types III-VI (medium to dark skin tones) are significantly more susceptible due to higher melanocyte activity. The severity and duration of the underlying inflammation directly correlate with PIH severity. Sun exposure during the healing period dramatically worsens PIH by stimulating additional melanin production. Genetic predisposition plays a role, and hormonal factors, particularly oestrogen, can exacerbate melanin production.
Treatment Approaches
1. Sun Protection (The Foundation)
Strict sun protection is the single most important element of PIH management. UV radiation stimulates tyrosinase activity and melanin production, directly worsening existing PIH and preventing resolution of treated areas. A broad-spectrum SPF 50 sunscreen containing both UVA and UVB filters should be applied daily — even on cloudy days and during winter months in the UK. Tinted sunscreens containing iron oxides provide additional protection against visible light, which can also stimulate melanogenesis in darker skin tones.
2. Topical Treatments
Tyrosinase Inhibitors
Hydroquinone (2-4%) remains the most studied and effective topical treatment for PIH. It works by inhibiting tyrosinase, the enzyme responsible for melanin synthesis. In the UK, hydroquinone at concentrations above 2% requires a prescription. It is typically used for 3-6 month courses with breaks to avoid potential side effects including paradoxical darkening (ochronosis) with prolonged use. Alternatives include arbutin (a natural hydroquinone derivative), kojic acid, azelaic acid (15-20%, which also has anti-inflammatory and anti-acne properties), tranexamic acid (topical, 2-5%, increasingly popular due to excellent safety profile), and vitamin C (L-ascorbic acid, 10-20%, which also provides antioxidant protection).
Retinoids
Tretinoin (0.025-0.1%) accelerates epidermal cell turnover, dispersing melanin through faster shedding of pigmented keratinocytes. It also inhibits melanin transfer from melanocytes to keratinocytes. Retinoids are particularly effective when combined with tyrosinase inhibitors. Adapalene is a retinoid alternative with additional anti-inflammatory properties that may be better tolerated in sensitive skin.
Chemical Exfoliants
Glycolic acid (5-15% in home care products) and salicylic acid promote exfoliation of pigmented surface cells, accelerating the visible clearance of epidermal PIH.
3. Professional Treatments
Chemical Peels
Carefully selected chemical peels can effectively treat PIH, but peel selection is critical — particularly in darker skin tones, where aggressive peels can actually cause more PIH. Mandelic acid peels are the safest option for darker skin, providing gentle exfoliation with minimal inflammation risk. Glycolic acid peels at moderate concentrations (30-50%) improve pigmentation when performed in a series. Modified Jessner’s peels can be effective but require experienced application. Salicylic acid peels offer the added benefit of oil-soluble penetration, helpful when PIH is associated with acne.
Laser and Light-Based Treatments
Certain laser modalities can target melanin deposits. The Q-switched Nd:YAG laser (1064nm) is the safest option for darker skin tones and can address both epidermal and dermal PIH. Low-fluence settings and multiple sessions are preferred to avoid triggering further PIH. Fractional non-ablative lasers (such as 1540nm or 1550nm) stimulate collagen remodelling and can gradually improve pigmentation. IPL can be effective for epidermal PIH in lighter skin tones but carries higher risk of worsening pigmentation in Fitzpatrick IV-VI.
Microneedling
Microneedling at conservative depth (0.5-1.0mm) can improve PIH by stimulating skin renewal and enhancing the penetration of topical depigmenting agents applied immediately after treatment. Studies have shown microneedling combined with tranexamic acid or vitamin C serums produces superior results compared to either approach alone.
4. Combination Therapy
The most effective approach to PIH typically combines multiple modalities. A common evidence-based protocol includes daily broad-spectrum SPF 50 sunscreen (non-negotiable foundation), a prescription-strength depigmenting cream (such as the modified Kligman formula containing hydroquinone, tretinoin, and a mild corticosteroid) used for 3-6 months, monthly superficial chemical peels to accelerate epidermal turnover, and transition to a maintenance regimen with vitamin C, niacinamide, and non-hydroquinone brightening agents.
Prevention of PIH
Preventing PIH is far easier than treating it. Before aesthetic procedures, patients at higher risk (darker skin tones, history of PIH) should undergo a 2-4 week skin priming regimen with topical retinoids and depigmenting agents. The least aggressive effective treatment should always be selected. Post-procedure sun protection must be rigorous and non-negotiable. Anti-inflammatory agents during the healing period can reduce the inflammatory trigger for melanin production. Test patches before aggressive treatments (lasers, medium-depth peels) help assess individual response.
When to Seek Specialist Help
Patients should consider referral to a consultant dermatologist if PIH has not responded to 6 months of appropriate topical therapy, if the pigmentation is deep (dermal) or mixed, if the PIH covers large areas of visible skin causing significant psychological impact, or if the underlying cause of inflammation has not been controlled. In the UK, NHS dermatology services can assess and treat PIH, though waiting times vary. Private dermatologists can offer faster access and may have access to advanced laser technologies.
Expert Clinical Insight
PIH requires patience — both from the patient and the practitioner. The most common mistake is treating too aggressively in an attempt to speed resolution, which often triggers further inflammation and worsens the pigmentation. Our approach is always conservative and stepped: start with a solid topical regimen and sun protection, assess the response at 8-12 weeks, and then consider adding professional treatments. This measured approach produces the best long-term outcomes with the least risk of setback.
— Axiom Aesthetics Clinical Team
Frequently Asked Questions
How long does post-inflammatory hyperpigmentation take to fade?
Epidermal PIH typically fades within 3-12 months with appropriate treatment and sun protection. Without treatment, it may persist for 6-18 months or longer. Dermal PIH is more persistent and may take years to fade, and in some cases may be permanent without treatment. The timeline is influenced by skin type, the depth of pigmentation, sun exposure, and the treatments employed. Consistent daily sun protection is the single most important factor in resolution speed.
Can PIH become permanent?
Epidermal PIH is rarely permanent and almost always fades with time and treatment. However, dermal PIH — where melanin has dropped into the deeper layers of the skin — can become permanent if untreated. Deep inflammatory events (such as severe cystic acne, deep burns, or aggressive laser treatments on predisposed skin) are most likely to cause dermal PIH. Early intervention with appropriate topical therapy and sun protection gives the best chance of complete resolution.
Is PIH the same as melasma?
No, PIH and melasma are distinct conditions, though they can look similar and sometimes coexist. PIH develops at the site of previous inflammation (acne spots, injury sites, procedure areas) and is directly caused by that inflammation. Melasma is a chronic pigmentation disorder that appears in characteristic patterns (typically the cheeks, forehead, and upper lip) and is driven by hormonal factors and UV exposure rather than focal inflammation. The treatment approaches overlap but are not identical — melasma tends to be more persistent and recurrence-prone.
Can aesthetic treatments cause PIH?
Yes, any aesthetic treatment that creates inflammation in the skin carries a risk of triggering PIH, particularly in patients with darker skin tones. Treatments with higher PIH risk include ablative laser resurfacing, medium-to-deep chemical peels, aggressive microneedling, and IPL in darker skin types. This risk can be significantly reduced through proper patient selection, pre-treatment skin priming, conservative treatment parameters, and strict post-treatment sun protection. A knowledgeable practitioner will discuss PIH risk before any procedure.
What is the best over-the-counter product for PIH?
The most effective over-the-counter ingredients for PIH include vitamin C serum (10-20% L-ascorbic acid), niacinamide (4-5%), alpha arbutin (2%), azelaic acid (10% OTC, 15-20% prescription), tranexamic acid, and retinol (0.3-1%). Combined with daily SPF 50 sunscreen, these ingredients form the foundation of an effective PIH treatment regimen. For more stubborn pigmentation, prescription-strength products (tretinoin, hydroquinone) from a dermatologist may be necessary.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hyperpigmentation can have various causes requiring different treatments. Always consult a qualified dermatologist or aesthetic practitioner for accurate diagnosis and personalised treatment recommendations. Some treatments mentioned require prescription and medical supervision.
Related reading: Aesthetic Treatments for Acne-Prone Skin | The Complete Guide to Facial Peels | The Role of Retinoids in Aesthetic Medicine
This content is provided for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with a qualified medical professional before undergoing any treatment. All treatments carry potential risks and side effects which will be fully discussed during your consultation.
Medical Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with a qualified medical professional before undergoing any treatment. All treatments carry potential risks and side effects which will be fully discussed during your consultation.